Microbial Products Market Research Report - Forecast to 2023

Microbial Products Market Research Report - Forecast to 2023

ID: MRFR/HC/0281-HCRR | June, 2018 | Region: Global | 139 pages | Half-Cooked Research Reports


Microbial Products Market Information: By Types (Enzymes, Polysaccharides, Nutrients (Amino Acids, Nucleotides, Vitamins, And Organic Acids), Chemotherapeutic Agents, Antibiotics, Vaccines, Others) By Source (Bacterial, Viral, Fungi, Others) By Applications (Pharmaceutical, Diagnostic, Biotechnology, Others) By End Users (pharmaceutical and biotechnological industries, hospitals and clinics, diagnostic labs, research and academics, others) - Global Forecast till 2023


Synopsis of Global Microbial products market:


Market scenario:


A microbe is a microscopic living organism, such as a bacteria, yeast, or fungus. Microbial products are produced by microbes and industrial microbiology is a branch of biotechnology which deals with the field. Microbes have been utilized for centuries to produce bread, cheese, wine, vinegar.. Medicinal microbiology include production of enzymes, antibiotics, nutrients such as amino acids, vitamins, and organic acids, chemotherapeutic agents, vaccines etc. Penicillin production is a classic example of microbial product for medicinal use. Beer was the first commercial product which dates back to around 1750 BC developed by the ancient Sumerians. Another application of microbial products is the manufacture of solvents and reagents such as ethanol, lactic acid, butanol etc. Synthesis of amino acids such as are L-Methionine, L-Lysine, L-Tryptophan, L-Glutamic acid etc. are another use of industrial microbiology for production of microbial products.


Fermentation technology is the most applied method for manufacturing of microbial products which converts sugars into gas, alcohols or acids. Advances in fermentation technology has the potential to change the way microbial products are produced.  Until recently, fermentation depended on limited raw materials and microbial strains which had a low yield. However, genetic recombinant technology is being used to manipulate microbes to increase their efficiency and make them capable to use a wide variety of raw materials. Reengineered microbes can produce microbial products more economically and naturally. Biotechnology has advanced to the level of engineering microorganisms to increase the yield of microbial products using ways such as introduction of mutations into an organism, gene amplification using plasmids, and vectors.


The market for microbial products is driven by factors such as growing prevalence of diseases, rising demand for healthcare nutrients such as vitamins, rising rates of cancers, rising demand for diagnostics microbial products, rise of lifestyles industry recommending many of these products etc. The constraints on the market are the highly fragmented nature of the industry, pressures on profits due to cut throat competition, secrecy surrounding the fermentation process, substandard and low quality producers operating from unknown locations etc.


Considering all these factors, the market for microbial products diagnosis and treatment is expected to reach $ 250.3 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.7 % during 2017-2023.

microbial products Methodology


Sources: Mayo Clinic, MRFR Analysis.


Intended Audience



  • Global Microbial products diagnosis and treatment solutions, manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities


Global Microbial products market by Applications, 2016 (% Market Share)


 Microbial products market


Segments:


The global microbial products market is segmented on the basis of types, source, applications and end users. Based on types, the market has been segmented as enzymes, polysaccharides, nutrients (amino acids, nucleotides, vitamins, and organic acids, others), chemotherapeutic agents, antibiotics, vaccines, others. Based on the source, the market has been segmented as bacterial, viral, fungi and others. Based on the applications, the market has been segmented as pharmaceutical, diagnostic, biotechnology and others. Based on the end users, the market has been segmented into pharmaceutical and biotechnological industries, hospitals & clinics, diagnostic labs, research & academics and others.


Regional analysis


US accounts for the maximum market share due to favorable insurance penetration, excellent reimbursement scenario and greater expenditure on healthcare. The high per capita consumption of microbial products due to high per capita income also drives the market. The faster market uptake of new technology in the US is also an important driver of the market for global microbial products. Europe is the second largest market due to large disposable income and rising consumption patterns. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.


Key players of Global Microbial products market:


Key players profiled in the report are Amgen Inc., Merck & Co.,Inc., Valent BioSciences Corp., GlaxoSmithKline plc, Pfizer Inc., bioMérieux SA, Ajinomoto Co.Inc., Sanofi S.A, Novartis AG, NovaDigm Therapeutics, Kyowa Hakko Bio Co., Ltd. and others.


The report for Global Microbial products market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.


Table of contents



1. Introduction

1.1 Definition

1.2 scope of study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3. Market dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market factor analysis

4.1 Porter’s Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5. Global Microbial Products market, by Types

5.1 Introduction

5.2 Enzymes

5.3 Polysaccharides

5.4 Nutrients

5.4.1 Amino Acids

5.4.2 Nucleotides

5.4.3 Vitamins

5.4.4 Organic Acids

5.4.5 Others

5.5 Chemotherapeutic Agents

5.6 Antibiotics

5.7 Vaccines

5.8 Others

6. Global Microbial Products market, By Source

6.1 Introduction

6.2 Bacterial

6.3 Viral

6.4 Fungi

6.5 Others

7. Global Microbial Products market, by Applications

7.1 Introduction

7.2 Pharmaceutical

7.3 Diagnostic

7.4 Biotechnology

7.5 Others

8. Global Microbial Products market, By End Users

8.1 Pharmaceutical and Biotechnological Industries

8.2 Hospitals and Clinics

8.3 Diagnostic Labs

8.4 Research and Academics

8.5 Others

9. Global Microbial Products market, By Region

9.1 North America

9.1.1 Introduction

9.2 Europe

9.2.1 Introduction

9.3 Asia-Pacific

9.3.1 Introduction

9.4 Middle East & Africa

9.4.1 Introduction

10. Competitive landscape

10.1 Major Strategies Adopted By Market Players

10.1.1 Strategic Partnership

10.1.2 Merger & Acquisition

11. Company profile

11.1 Amgen Inc.

11.1.1 Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 Key Developments

11.2 Merck & Co.

11.2.1 Overview

11.2.2 Product Overview

11.2.3 Financials

11.2.4 Key Developments

11.3 Valent BioSciences Corp.

11.3.1 Overview

11.3.2 Product Overview

11.3.3 Financials

11.3.4 Key Development

11.4 GlaxoSmithKline plc

11.4.1 Overview

11.4.2 Product Overview

11.4.3 Financials

11.4.4 Key Developments

11.5 Pfizer Inc.

11.5.1 Overview

11.5.2 Product Overview

11.5.3 Financials

11.5.4 Key Developments

11.6 bioMérieux SA

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.7 Ajinomoto Co.Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.8 Sanofi S.A

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.9 Novartis AG

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.10 NovaDigm Therapeutics

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.11 Kyowa Hakko Bio Co., Ltd.

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.12 Others

12. Conclusion

12.1 Key Findings

12.1.1 From Ceo’s Viewpoint

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Microbial Products Industry

13. Appendix





List of Tables

Table 1 Microbial Products Industry Synopsis, 2017–2023

Table 2 Global Microbial Products Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Global Microbial Products Market, by Region, 2017–2023, (USD Million)

Table 4 Global Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 5 Global Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 6 Global Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 7 Global Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 8 North America Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 9 North America Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 10 North America Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 11 North America Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 12 U.S. Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 13 U.S. Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 14 U.S. Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 15 U.S. Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 16 Canada Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 17 Canada Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 18 Canada Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 19 Canada Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 20 South America Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 21 South America Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 22 South America Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 23 South America Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 24 Europe Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 25 Europe Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 26 Europe Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 27 Europe Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 28 Western Europe Microbial Products Market by Type, 2017–2023, (USD Million)

Table 29 Western Europe Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 30 Western Europe Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 31 Western Europe Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 32 Eastern Europe Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 33 Eastern Europe Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 34 Eastern Europe Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 35 Eastern Europe Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 36 Asia Pacific Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 37 Asia Pacific Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 38 Asia Pacific Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 39 Asia Pacific Microbial Products Market, by End-User, 2017–2023, (USD Million)

Table 40 Middle East & Africa Microbial Products Market, by Type, 2017–2023, (USD Million)

Table 41 Middle East & Africa Microbial Products Market, by Source, 2017–2023, (USD Million)

Table 42 Middle East & Africa Microbial Products Market, by Application, 2017–2023, (USD Million)

Table 43 Middle East & Africa Microbial Products Market, by End-User, 2017–2023, (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Microbial Product Market

Figure 3 Segmentation Market Dynamics for Microbial Product Market

Figure 4 Global Microbial Product Market Share, by Type 2016

Figure 5 Global Microbial Product Market Share, by Source 2016

Figure 6 Global Microbial Product Market Share, by Application 2016

Figure 7 Global Microbial Product Market Share, by End-User, 2016

Figure 8 Global Microbial Product Market Share, by Region, 2016

Figure 9 North America Microbial Product Market Share, by Country, 2016

Figure 10 Europe Microbial Product Market Share, by Country, 2016

Figure 11 Asia Pacific Microbial Product Market Share, by Country, 2016

Figure 12 Middle East & Africa Microbial Product Market Share, by Country, 2016

Figure 13 Global Microbial Product Market: Company Share Analysis, 2016 (%)